Acquisition of Diphtheria and Tetanus Vaccine (Td Reduced Dose) [UDOSE] under Framework Agreement 2024/963

This tender involves the acquisition of a dual vaccine against diphtheria and tetanus, specifically the reduced dose formulation (Td Reduced Dose) known as UDOSE. The procurement is conducted under the framework agreement 2024/963, which outlines the terms and conditions for the acquisition process. The primary objective of this tender is to ensure the availability of the vaccine for public health initiatives, particularly in vaccination programs aimed at preventing these diseases. Key requirements for bidders may include compliance with regulatory standards for vaccine production and distribution, as well as the ability to meet delivery timelines specified in the framework agreement. The tender is relevant to the healthcare sector, focusing on immunization efforts. Interested parties should prepare to demonstrate their capacity to fulfill the contract requirements, including quality assurance measures and logistical capabilities. Further details regarding submission deadlines and evaluation criteria will be provided in the tender documentation.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 12,640.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.